Frontlight ResearchEarly access
Pompe disease trials in Taiwan
1 of 4 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3WithdrawnA Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
- Where
- Taipei
- Age
- Up to 17 years
- People
- 36 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT04808505 · EU 2022-501095-25-01